UMMS Affiliation

Commonwealth Medicine, Center for Health Policy and Research; Department of Family Medicine and Community Health; Department of Quantitative Health Sciences

Publication Date

2013-07-20

Document Type

Presentation

Disciplines

Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Substance Abuse and Addiction

Abstract

This presentation discusses the impact of prior authorization on Buprenorphine dose, relapse, and cost for opioid addiction treatment for Massachusetts Medicaid members.

Presented at the AcademyHealth Annual Research Meeting 2013.

Keywords

Drug addiction treatment, Medicaid, buprenorphine, pharmaceutical policy, prior authorization, opioid treatment

DOI of Published Version

10.13028/kwyc-1452

Journal/Book/Conference Title

Commonwealth Medicine Publications

Share

COinS